WELL Health Technologies Management
Management criteria checks 4/4
WELL Health Technologies' CEO is Hamed Shahbazi, appointed in May 2018, has a tenure of 7.08 years. total yearly compensation is CA$1.25M, comprised of 40.1% salary and 59.9% bonuses, including company stock and options. directly owns 5.87% of the company’s shares, worth CA$56.75M. The average tenure of the management team and the board of directors is 6.2 years and 7.2 years respectively.
Key information
Hamed Shahbazi
Chief executive officer
CA$1.2m
Total compensation
| CEO salary percentage | 40.13% |
| CEO tenure | 7.1yrs |
| CEO ownership | 5.9% |
| Management average tenure | 6.2yrs |
| Board average tenure | 7.2yrs |
Recent management updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)
Apr 23
Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts
Apr 22WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%
Apr 01Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?
Mar 29
AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline
Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well
Dec 31A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb
Nov 29When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?
Nov 11Is WELL Health Technologies (TSE:WELL) A Risky Investment?
Sep 09Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher
Jul 05WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price
Jun 11WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem
May 21WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Mar 21Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?
Feb 29The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)
Jan 18WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Oct 30We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt
Jul 17WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly
Apr 18Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?
Jan 13Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?
Nov 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -CA$25m |
| Dec 31 2024 | CA$1m | CA$500k | CA$33m |
| Sep 30 2024 | n/a | n/a | CA$69m |
| Jun 30 2024 | n/a | n/a | CA$143m |
| Mar 31 2024 | n/a | n/a | CA$25m |
| Dec 31 2023 | CA$7m | CA$500k | CA$82k |
| Sep 30 2023 | n/a | n/a | -CA$7m |
| Jun 30 2023 | n/a | n/a | -CA$4m |
| Mar 31 2023 | n/a | n/a | -CA$5m |
| Dec 31 2022 | CA$2m | CA$450k | CA$1m |
| Sep 30 2022 | n/a | n/a | -CA$29m |
| Jun 30 2022 | n/a | n/a | -CA$37m |
| Mar 31 2022 | n/a | n/a | -CA$45m |
| Dec 31 2021 | CA$5m | n/a | -CA$44m |
| Sep 30 2021 | n/a | n/a | -CA$29m |
| Jun 30 2021 | n/a | n/a | -CA$21m |
| Mar 31 2021 | n/a | n/a | -CA$9m |
| Dec 31 2020 | CA$710k | n/a | -CA$4m |
| Sep 30 2020 | n/a | n/a | -CA$9m |
| Jun 30 2020 | n/a | n/a | -CA$10m |
| Mar 31 2020 | n/a | n/a | -CA$8m |
| Dec 31 2019 | CA$681k | n/a | -CA$8m |
| Dec 31 2018 | CA$502k | n/a | -CA$2m |
Compensation vs Market: Hamed's total compensation ($USD906.83K) is below average for companies of similar size in the Canadian market ($USD1.91M).
Compensation vs Earnings: Hamed's compensation has been consistent with company performance over the past year.
CEO
Hamed Shahbazi (50 yo)
Mr. Hamed Shahbazi, B. Sc., serves as Chairman & Chief Executive Officer at WELL Ventures. He is Chairman of the Board of Healwell AI Inc. from February 2024. He was Director of Healwell AI Inc. from Octob...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7.1yrs | CA$1.25m | 5.87% CA$ 56.7m | |
| Chief Financial Officer | 6.2yrs | CA$564.21k | 0.78% CA$ 7.5m | |
| Chief Operating Officer | 6.4yrs | CA$564.21k | 0.81% CA$ 7.9m | |
| CEO of WELL Health USA & CRH Medical | 3.4yrs | CA$1.16m | no data | |
| Chief Executive Officer of MyHealth Partners Inc. | 2.3yrs | CA$794.02k | no data | |
| Chief Accounting Officer | less than a year | no data | no data | |
| Vice President of Corporate Strategy & Investor Relations | 6.2yrs | no data | no data | |
| Senior Vice President of Corporate Development | 6.2yrs | CA$302.30k | no data | |
| Senior Vice President of Strategic Partnerships & Marketing | 6.4yrs | no data | no data | |
| Chief People Officer | 4.4yrs | no data | no data | |
| Chief Medical Officer | 6.6yrs | CA$639.73k | no data | |
| Head of Acquisitions - Eastern Canada | 4.9yrs | no data | no data |
Experienced Management: WELL's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.3yrs | CA$1.25m | 5.87% CA$ 56.7m | |
| Independent Director | 7.2yrs | CA$219.16k | 0.26% CA$ 2.5m | |
| Independent Director | 9.3yrs | CA$209.21k | 0.19% CA$ 1.8m | |
| Independent Director | 7.3yrs | CA$209.21k | 0.16% CA$ 1.5m | |
| Member of Advisory Board | 5.8yrs | no data | no data | |
| Independent Director | 5.2yrs | CA$209.21k | 0.047% CA$ 453.0k | |
| Independent Director | 2.8yrs | CA$169.10k | 0.22% CA$ 2.1m |
Experienced Board: WELL's board of directors are considered experienced (7.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/22 21:41 |
| End of Day Share Price | 2025/06/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
WELL Health Technologies Corp. is covered by 15 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gabriel Leung | Beacon Securities Limited |
| Douglas Taylor | Canaccord Genuity |
| Scott Fletcher | CIBC Capital Markets |